Corcept Therapeutics Inc
CORT· Nasdaq
Released Aug 4, 2020, after the close
10-Q filed Aug 4, 2020, 35 days after period end · 0001628280-20-011656
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $88.57M | $72.26M | $62.31M | $35.56M |
| Net Income | $28.33M | $20.19M | $18.20M | $12.65M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.23 |
| $0.17 |
| $0.14 |
| $0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.